Duration of vasomotor symptoms in middle-aged women: a longitudinal study
Nananda F Col, Janet R Guthrie, Mary Politi, Lorraine Dennerstein
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2009
OBJECTIVE: Vasomotor symptoms adversely affect the quality of life and functional status of most women during the menopausal transition, but little is known about how long these symptoms last. The most effective treatment, hormone therapy (HT), carries risks and benefits that depend on the timing and duration of use. In this study we sought to estimate the duration of vasomotor symptoms in a longitudinal study. METHODS: We reanalyzed primary data from 438 women in the longitudinal cohort of the population-based Melbourne Women's Midlife Health Project. Two hundred and five women who had completed 13 years of follow-up were included in the analyses. The onset and cessation of vasomotor sympto..View full abstract
Awarded by Agency for Healthcare, Research, and Quality
Awarded by AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
Funding/support: This work was supported by the Agency for Healthcare, Research, and Quality 2R01 HS013329-04Al. The Melbourne Wornen's Midlife Health Project has been funded by the Victorian Health Prornotion Foundation, the Australian National Health and Medical Research Council, ANZ Trustees, and Perpetual Trustees.